Europe must secure medicines as part of its defence, regions and cities stress

The European Committee of the Regions (CoR) is calling on the European Union to reinforce the proposed Critical Medicines Act (CMA) to tackle rising medicine shortages and strengthen Europe's pharmaceutical security. In an opinion led by Erika Von Kalben (DE/Greens) and adopted unanimously on 10 December, regional and local leaders call for health security to be part of EU's new security paradigm and for a formal role for regions in implementing the new rules.

Medicine shortages have surged in Europe over the past decade, putting patients at risk and straining healthcare systems. The CoR warns that Europe's heavy reliance on third countries - particularly for antibiotics and essential ingredients - has become a strategic vulnerability amid rising geopolitical tensions. Because medicines are not only vital for civilian healthcare, but also for military and emergency scenarios, regions call for clear recognition of the importance of health security within the European Defence Industrial Strategy.

To boost resilience, the CoR calls for dedicated funding to expand manufacturing in the EU, support small and medium-sized enterprises and develop innovative, cleaner production technologies. Public financial support should come with clear obligations, including supply guarantees and transparency in the use of funds.

Because many health systems are managed at regional level, the CoR demands that regional authorities be fully involved in identifying strategic projects, designing funding schemes and ensuring projects comply with local environmental and land-use rules. Regions also call for more support to upgrade skills, develop specialised training, and build a resilient workforce in pharmaceutical production and shortage management.

Finally, to improve access and affordability for patients, the CoR encourages Member States to make greater use of joint procurement and calls for the European Commission to be allowed to negotiate medicine prices when requested. It also stresses the need for stronger solidarity mechanisms so that all Member States - including smaller markets - can secure critical medicines during shortages.

Quote

Rapporteur Erika Von Kalben (DE/Greens), Member of the State Parliament of Schleswig-Holstein: "Medicine shortages are a growing threat to Europe's health systems and our security. The Critical Medicines Act is a key opportunity to strengthen Europe's resilience - but only if regions are firmly involved. Our opinion reinforces regional cooperation to secure a reliable supply of essential medicines, a cornerstone of an independent and united Europe in uncertain times."

Background

• Video and photos from the session.

• On 2 December 2025, the Council agreed its position on a new regulation that seeks to strengthen the EU's resilience in the face of ongoing challenges to the security of supply of critical medicines in Europe. More information.

Contact

Hélène Dressen Tel: +32 471502795 [email protected]